Norinchukin Bank The raised its stake in Thermo Fisher Scientific Inc. (NYSE:TMO) by 3.6% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 76,407 shares of the medical research company’s stock after acquiring an additional 2,671 shares during the period. Norinchukin Bank The’s holdings in Thermo Fisher Scientific were worth $20,914,000 as of its most recent SEC filing.
Several other institutional investors have also added to or reduced their stakes in the stock. Vanguard Group Inc raised its stake in shares of Thermo Fisher Scientific by 1.2% in the third quarter. Vanguard Group Inc now owns 29,271,095 shares of the medical research company’s stock worth $7,144,489,000 after buying an additional 347,836 shares during the period. Providence Capital Advisors LLC raised its position in Thermo Fisher Scientific by 5.6% during the 4th quarter. Providence Capital Advisors LLC now owns 9,969 shares of the medical research company’s stock valued at $2,231,000 after purchasing an additional 526 shares in the last quarter. United Income Inc. bought a new position in shares of Thermo Fisher Scientific in the 4th quarter worth $1,736,000. Balasa Dinverno & Foltz LLC raised its position in shares of Thermo Fisher Scientific by 2.1% in the 4th quarter. Balasa Dinverno & Foltz LLC now owns 2,238 shares of the medical research company’s stock worth $501,000 after acquiring an additional 46 shares in the last quarter. Finally, Alerus Financial NA bought a new position in shares of Thermo Fisher Scientific in the 4th quarter worth $2,961,000. 87.96% of the stock is currently owned by institutional investors.
In related news, Director C Martin Harris sold 275 shares of the company’s stock in a transaction dated Wednesday, June 5th. The stock was sold at an average price of $270.73, for a total value of $74,450.75. Following the completion of the transaction, the director now owns 6,433 shares of the company’s stock, valued at approximately $1,741,606.09. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Stephen Williamson sold 2,500 shares of the company’s stock in a transaction dated Monday, June 3rd. The stock was sold at an average price of $268.29, for a total value of $670,725.00. Following the completion of the transaction, the chief financial officer now directly owns 40,029 shares of the company’s stock, valued at approximately $10,739,380.41. The disclosure for this sale can be found here. Insiders sold a total of 53,488 shares of company stock valued at $14,600,474 in the last ninety days. 0.45% of the stock is currently owned by insiders.
NYSE TMO traded down $1.44 during trading hours on Wednesday, reaching $283.61. The company’s stock had a trading volume of 7,457 shares, compared to its average volume of 1,645,002. The stock has a market capitalization of $113.70 billion, a price-to-earnings ratio of 25.46, a PEG ratio of 1.85 and a beta of 1.08. Thermo Fisher Scientific Inc. has a 1-year low of $202.83 and a 1-year high of $288.07. The company has a current ratio of 1.69, a quick ratio of 1.16 and a debt-to-equity ratio of 0.61.
Thermo Fisher Scientific (NYSE:TMO) last released its quarterly earnings results on Wednesday, April 24th. The medical research company reported $2.81 earnings per share for the quarter, topping analysts’ consensus estimates of $2.74 by $0.07. The company had revenue of $6.13 billion during the quarter, compared to analysts’ expectations of $6.04 billion. Thermo Fisher Scientific had a return on equity of 17.06% and a net margin of 12.89%. Thermo Fisher Scientific’s quarterly revenue was up 4.6% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $2.50 EPS. Equities analysts predict that Thermo Fisher Scientific Inc. will post 12.2 EPS for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, July 16th. Investors of record on Friday, June 14th will be issued a $0.19 dividend. The ex-dividend date is Thursday, June 13th. This represents a $0.76 dividend on an annualized basis and a yield of 0.27%. Thermo Fisher Scientific’s payout ratio is 6.83%.
COPYRIGHT VIOLATION WARNING: “Norinchukin Bank The Buys 2,671 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO)” was posted by Ticker Report and is owned by of Ticker Report. If you are accessing this piece of content on another publication, it was copied illegally and republished in violation of US and international trademark and copyright laws. The legal version of this piece of content can be viewed at https://www.tickerreport.com/banking-finance/4369222/norinchukin-bank-the-buys-2671-shares-of-thermo-fisher-scientific-inc-nysetmo.html.
Thermo Fisher Scientific Company Profile
Thermo Fisher Scientific Inc provides analytical and other instruments, laboratory equipment, software, consumables, reagents, instrument systems, chemicals, supplies, and services under the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide.
Featured Article: How is inflation measured?
Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO).
Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.